ArticleEClinicalMedicine2021

Association of partial systemic exposure and abuse potential for opioid analgesics with abuse deterrence labeling claims supporting product-specific guidance.

Liang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.